Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus midazolam for sedation during diagnostic upper GI endoscopy
NL-OMON59191Phase 4Recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing Remimazolam arm with Midazolam arm (2 arms). Primary endpoint: Time to full alertness. Started Oct 2024; status: recruiting.
02
Drugs
remimazolammidazolam
Beyond the preview
Go deeper on NL-OMON59191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59191.